Underrepresented patient populations in cardiovascular device trials: A transatlantic expert narrative on sex, age, demographic groups, and geographical background


Por: Spitzer, E, Costa, F, Gudmundsdóttir, IJ, Hernández, JMD, Testa, L, McFadden, E, Hanet, C, Daemen, J, Van Belle, E, Iglesias, JF, Allocco, D, Dietzsch, S, Jönsson, A, Slots, T, Negoita, M, Hutson, CS, Larrubia-Valle, JI, Paredes, XS, Erlinge, D, Kandzari, DE, Ren, CB, de Prado, AP, Boersma, E, Pibarot, P, Tijssen, JGP, Banning, AP, Cutlip, DE, Delgado, V and Krucoff, MW

Publicada: 15 ene 2026 Ahead of Print: 1 sep 2025
Resumen:
External validity of clinical research can be optimized by an adequate representation of all patient groups within a disease spectrum. This emphasizes the need of enrolling patient groups who have been historically underrepresented on the basis of sex, age, demographic groups, or geographical background. Especially in countries with pronounced disparities, raising awareness regarding the existing gaps in future clinical studies continues to be a priority. Census-defined demographic minority groups have been reported to have less access to high-quality healthcare, are less studied in clinical trials, and have less group-specific high-quality data on outcomes after treatment. Additionally, efforts should continue towards enrolling a balanced or at least representative distribution of women and men in clinical trials; and, enrolling age ranges that are consistent with patients suffering from the index disease. Aiming for heterogeneity in study populations will undoubtedly contribute to advancements in medicine, the development of improved therapies, and better outcomes. Analyses on demographic groups have revealed significant disparities within some regions of the world, underlining the need to further investigate whether access to advanced therapies is consistently offered to all members of a nation. To foster international collaboration in cutting-edge clinical research with adequate patient representation, this document presents insights and consensus on fundamental issues, including available classifications of demographic groups in Europe and North America, and presents a standardized approach for collecting geographical background data.

Filiaciones:
Spitzer, E:
 Cardialysis, Rotterdam, Netherlands

 European Cardiovasc Res Inst, Rotterdam, Netherlands

Costa, F:
 Univ Hosp Virgen de la Victoria, Malaga Univ, Heart Ctr, Med Dept, Malaga, Spain

 Ctr Invest Biomed Red Enfermedades Cardiovasc CIBE, Malaga, Spain

 Univ Messina, Biomed & Dent Sci & Morphol & Funct Images Dept, Messina, Italy

Gudmundsdóttir, IJ:
 Landspitali Univ Hosp, Cardiol Dept, Reykjavik, Iceland

 Univ Iceland, Reykjavik, Iceland

Hernández, JMD:
 Univ Hosp Marques de Valdecilla, Cardiol Dept, IDIVAL, Santander, Spain

 EPIC Fdn, Leon, Spain

Testa, L:
 IRCCS Policlin San Donato, Cardiol Dept, Milan, Italy

McFadden, E:
 Cork Univ Hosp, Cardiol Dept, Cork, Ireland

Hanet, C:
 Univ Louvain, Brussels, Belgium

Daemen, J:
 Erasmus MC, Cardiovasc Inst, Thoraxctr, Rotterdam, Netherlands

Van Belle, E:
 Ctr Hosp Reg Univ, Inst Coeur Poumon, INSERM, U1011, Lille, France

Iglesias, JF:
 Geneva Univ Hosp, Cardiol Dept, Geneva, Switzerland

Allocco, D:
 Shockwave Med, Santa Clara, CA USA

Dietzsch, S:
 Siemens Healthineers AG, Forchheim, Germany

Jönsson, A:
 Biosensors Int, Morges, Switzerland

Slots, T:
 Pie Med Imaging, Maastricht, Netherlands

Negoita, M:
 Medtronic, Minneapolis, MN USA

Hutson, CS:
 Abbott Labs, Abbott Pk, IL USA

Larrubia-Valle, JI:
 Reg Univ Hosp, Cardiol Dept, Malaga, Spain

Paredes, XS:
 Cardialysis, Rotterdam, Netherlands

Erlinge, D:
 Lund Univ, Skane Univ Hosp, Cardiol Dept, Lund, Sweden

Kandzari, DE:
 Piedmont Heart Inst, Atlanta, GA USA

 Cardiovasc Serv, Atlanta, GA USA

 Piedmont Heart Inst, Cardiol Dept, Atlanta, GA, Georgia

Ren, CB:
 Cardialysis, Rotterdam, Netherlands

de Prado, AP:
 Hosp Univ Leon, Cardiol Dept, Leon, Spain

Pibarot, P:
 Laval Univ, Quebec Heart & Lung Inst, Dept Med, Quebec City, PQ, Canada

Tijssen, JGP:
 European Cardiovasc Res Inst, Rotterdam, Netherlands

Banning, AP:
 European Cardiovasc Res Inst, Rotterdam, Netherlands

 Oxford Univ Hosp, Cardiol Dept, John Radcliffe, Oxford, England

Cutlip, DE:
 Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Cardiovasc Med, Boston, MA USA

 Baim Inst Clin Res, Boston, MA USA

:
 Univ Hosp Germans Trias i Pujol, Heart Inst, Badalona, Spain

 Res Inst Germans Trias i Pujol, Ctr Comparat Med & Bioimaging, Badalona, Spain

Krucoff, MW:
 Duke Univ, Duke Clin Res Inst, Durham, NC USA

 Duke Univ, Dept Med, Cardiol, Med Ctr, Durham, NC USA
ISSN: 01675273





International Journal of Cardiology
Editorial
Elsevier BV, ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND, Países Bajos
Tipo de documento: Article
Volumen: 443 Número:
Páginas: 133930-133930
WOS Id: 001588783700004
ID de PubMed: 41015124
imagen Green Submitted, Green Published, hybrid

MÉTRICAS